Rathbones Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $435K | Buy |
6,059
+90
| +2% | +$6.93K | ﹤0.01% | 464 |
|
|
2025
Q4 | $474K | Buy |
5,969
+1,691
| +40% | +$133K | ﹤0.01% | 459 |
|
|
2025
Q3 | $323K | Sell |
4,278
-635
| -13% | -$43.5K | ﹤0.01% | 505 |
|
|
2025
Q2 | $339K | Sell |
4,913
-1,000
| -17% | -$65.6K | ﹤0.01% | 484 |
|
|
2025
Q1 | $401K | Sell |
5,913
-2,115
| -26% | -$127K | ﹤0.01% | 436 |
|
|
2024
Q4 | $360K | Sell |
8,028
-690
| -8% | -$38.7K | ﹤0.01% | 458 |
|
|
2024
Q3 | $548K | Sell |
8,718
-155
| -2% | -$9.04K | ﹤0.01% | 405 |
|
|
2024
Q2 | $524K | Sell |
8,873
-1,282
| -13% | -$80.2K | ﹤0.01% | 408 |
|
|
2024
Q1 | $810K | Buy |
10,155
+132
| +1% | +$10.1K | ﹤0.01% | 348 |
|
|
2023
Q4 | $791K | Sell |
10,023
-6,000
| -37% | -$427K | 0.01% | 337 |
|
|
2023
Q3 | $1.12M | Buy |
16,023
+13,071
| +443% | +$926K | 0.01% | 303 |
|
|
2023
Q2 | $204K | Hold |
2,952
| – | – | ﹤0.01% | 374 |
|
|
2023
Q1 | $219K | Sell |
2,952
-100
| -3% | -$8.39K | ﹤0.01% | 376 |
|
|
2022
Q4 | $284K | Hold |
3,052
| – | – | ﹤0.01% | 343 |
|
|
2022
Q3 | $291K | Sell |
3,052
-230
| -7% | -$22.8K | ﹤0.01% | 338 |
|
|
2022
Q2 | $304K | Sell |
3,282
-21
| -0.6% | -$2.05K | ﹤0.01% | 346 |
|
|
2022
Q1 | $334K | Hold |
3,303
| – | – | ﹤0.01% | 346 |
|
|
2021
Q4 | $341K | Sell |
3,303
-99
| -3% | -$9.15K | ﹤0.01% | 348 |
|
|
2021
Q3 | $289K | Sell |
3,402
-11,000
| -76% | -$921K | ﹤0.01% | 357 |
|
|
2021
Q2 | $1.2M | Hold |
14,402
| – | – | 0.01% | 239 |
|
|
2021
Q1 | $1.08M | Hold |
14,402
| – | – | 0.01% | 238 |
|
|
2020
Q4 | $984K | Sell |
14,402
-130
| -0.9% | -$8.46K | 0.01% | 227 |
|
|
2020
Q3 | $849K | Sell |
14,532
-507
| -3% | -$31.5K | 0.01% | 223 |
|
|
2020
Q2 | $977K | Buy |
15,039
+104
| +0.7% | +$6.55K | 0.02% | 206 |
|
|
2020
Q1 | $886K | Sell |
14,935
-63
| -0.4% | -$4.21K | 0.03% | 185 |
|
|
2019
Q4 | $1.11M | Buy |
14,998
+35
| +0.2% | +$2.46K | 0.03% | 188 |
|
|
2019
Q3 | $944K | Sell |
14,963
-430
| -3% | -$25.5K | 0.03% | 193 |
|
|
2019
Q2 | $839K | Buy |
15,393
+1,850
| +14% | +$99.6K | 0.03% | 192 |
|
|
2019
Q1 | $730K | Buy |
13,543
+2,010
| +17% | +$124K | 0.02% | 193 |
|
|
2018
Q4 | $756K | Sell |
11,533
-1,445
| -11% | -$108K | 0.03% | 189 |
|
|
2018
Q3 | $1.02M | Sell |
12,978
-993
| -7% | -$71K | 0.03% | 174 |
|
|
2018
Q2 | $899K | Sell |
13,971
-1,842
| -12% | -$121K | 0.03% | 175 |
|
|
2018
Q1 | $984K | Sell |
15,813
-23,035
| -59% | -$1.65M | 0.04% | 174 |
|
|
2017
Q4 | $2.82M | Sell |
38,848
-10,130
| -21% | -$736K | 0.11% | 116 |
|
|
2017
Q3 | $3.98M | Sell |
48,978
-791
| -2% | -$62.6K | 0.17% | 93 |
|
|
2017
Q2 | $4M | Sell |
49,769
-57,282
| -54% | -$4.52M | 0.18% | 98 |
|
|
2017
Q1 | $8.4M | Sell |
107,051
-5,111
| -5% | -$408K | 0.38% | 72 |
|
|
2016
Q4 | $8.85M | Buy |
112,162
+8,116
| +8% | +$657K | 0.44% | 66 |
|
|
2016
Q3 | $9.26M | Buy |
104,046
+8,412
| +9% | +$794K | 0.48% | 60 |
|
|
2016
Q2 | $9.16M | Buy |
95,634
+9,471
| +11% | +$944K | 0.5% | 57 |
|
|
2016
Q1 | $8.94M | Buy |
86,163
+4,338
| +5% | +$422K | 0.54% | 50 |
|
|
2015
Q4 | $7.82M | Buy |
81,825
+18,364
| +29% | +$1.8M | 0.5% | 58 |
|
|
2015
Q3 | $6.12M | Buy |
63,461
+19,685
| +45% | +$2.07M | 0.41% | 65 |
|
|
2015
Q2 | $4.59M | Sell |
43,776
-187
| -0.4% | -$19.1K | 0.3% | 71 |
|
|
2015
Q1 | $4.54M | Buy |
43,963
+2,994
| +7% | +$303K | 0.3% | 71 |
|
|
2014
Q4 | $3.95M | Buy |
40,969
+32,114
| +363% | +$2.83M | 0.26% | 80 |
|
|
2014
Q3 | $705K | Buy |
8,855
+115
| +1% | +$9.07K | 0.05% | 170 |
|
|
2014
Q2 | $659K | Buy |
8,740
+4,180
| +92% | +$316K | 0.05% | 181 |
|
|
2014
Q1 | $341K | Buy |
+4,560
| New | +$322K | 0.03% | 218 |
|
Other funds holding CVS
VCM
VPM
Rathbones Group's CVS Position: Q1 2026 in Review
Rathbones Group increased its CVS Health (CVS) stake by 1.5% in Q1 2026, buying an estimated $6.93K and bringing the position to 6,059 shares worth $435K. The position accounts for ﹤0.01% of the portfolio, ranked #464.
Rathbones Group first reported a position in CVS in Q1 2014 and has held it in 49 quarters since. The position peaked at $9.26M in Q3 2016. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Rathbones Group held 6,059 shares of CVS Health worth $435K as of Q1 2026.
- Rathbones Group bought 90 CVS Health shares in Q1 2026, an estimated $6.93K.
- CVS Health made up ﹤0.01% of Rathbones Group's portfolio in Q1 2026, its #464 holding.
- Rathbones Group first reported a position in CVS Health in Q1 2014 and has held it in 49 quarters since.
- Rathbones Group's CVS Health position peaked at $9.26M in Q3 2016.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Rathbones Group's 13F filing for Q1 2026, filed 12 May 2026.